BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Revenue, 2025
- $48.2B
- YoY, 2025
- −0.2%
- 5-year CAGR
- +2.5%
- 10-year CAGR
- +11.3%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $48.2B | −0.2% |
| 2024 | $48.3B | +7.3% |
| 2023 | $45.0B | −2.5% |
| 2022 | $46.2B | −0.5% |
| 2021 | $46.4B | +9.1% |
| 2020 | $42.5B | +62.6% |
| 2019 | $26.1B | +15.9% |
| 2018 | $22.6B | +8.6% |
| 2017 | $20.8B | +6.9% |
| 2016 | $19.4B | +17.3% |
| 2015 | $16.6B | +4.3% |
| 2014 | $15.9B | −3.1% |
| 2013 | $16.4B | −7.0% |
| 2012 | $17.6B | −17.1% |
| 2011 | $21.2B | +9.0% |
| 2010 | $19.5B | +3.6% |
| 2009 | $18.8B | +6.2% |
| 2008 | $17.7B | +13.4% |
| 2007 | $15.6B | — |